We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.39B
AUM Growth
-$206M
Cap. Flow
+$24.9M
Cap. Flow %
0.57%
Top 10 Hldgs %
31.12%
Holding
1,194
New
99
Increased
241
Reduced
259
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 26.98%
2 Healthcare 19.12%
3 Financials 13.19%
4 Industrials 9.29%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQMS icon
1051
Aqua Metals
AQMS
$9.63M
$0 ﹤0.01%
2
ARVN icon
1052
Arvinas
ARVN
$518M
-96
Closed -$8K
AVNS icon
1053
Avanos Medical
AVNS
$1.17B
$0 ﹤0.01%
3
-12
-80% -$386
BAH icon
1054
Booz Allen Hamilton
BAH
$8.7B
-44
Closed -$4K
BBIO icon
1055
BridgeBio Pharma
BBIO
$16.5B
-131
Closed -$2K
BBVA icon
1056
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
-808
Closed -$5K
BE icon
1057
Bloom Energy
BE
$52.6B
-2,500
Closed -$55K
BIV icon
1058
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
-87
Closed -$8K
BNDX icon
1059
Vanguard Total International Bond ETF
BNDX
$82B
-180
Closed -$10K
BNTX icon
1060
BioNTech
BNTX
$22.6B
-30
Closed -$8K
BURL icon
1061
Burlington
BURL
$22B
-13
Closed -$4K
CACI icon
1062
CACI
CACI
$10.8B
-650
Closed -$175K
CDXS icon
1063
Codexis
CDXS
$135M
-724
Closed -$23K
CFLT
1064
DELISTED
Confluent
CFLT
-604
Closed -$46K
CHGG icon
1065
Chegg
CHGG
$108M
-324
Closed -$10K
CHH icon
1066
Choice Hotels
CHH
$5.03B
-24
Closed -$4K
CHKP icon
1067
Check Point Software Technologies
CHKP
$13.3B
-80
Closed -$9K
CLF icon
1068
Cleveland-Cliffs
CLF
$6.81B
-200
Closed -$4K
CM icon
1069
Canadian Imperial Bank of Commerce
CM
$107B
-260
Closed -$15K
CRL icon
1070
Charles River Laboratories
CRL
$10.9B
-30
Closed -$11K
CVNA icon
1071
Carvana
CVNA
$43.3B
-960
Closed -$45K
DIA icon
1072
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
-23
Closed -$8K
DNLI icon
1073
Denali Therapeutics
DNLI
$3.67B
-578
Closed -$26K
DNTH icon
1074
Dianthus Therapeutics
DNTH
$5.68B
-63
Closed -$4K
DUOL icon
1075
Duolingo
DUOL
$5.7B
-143
Closed -$15K

Similar funds

HM Payson & Co's Q1 2022 Portfolio in Review

As of Q1 2022, HM Payson & Co held 1,194 positions worth $4.39B, down 4.5% from $4.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HM Payson & Co's Q1 2022 filing shows 99 new, 241 increased, 259 reduced and 119 closed positions. Its largest new stake was Standex International: 6,344 shares worth $634K. The largest sale was Expeditors International, an estimated $21.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q1 2022 buy was Standex International: 6,344 shares worth $634K.
  • HM Payson & Co added most to Bristol-Myers Squibb in Q1 2022, an estimated $25.6M increase.
  • HM Payson & Co's biggest Q1 2022 reduction was Expeditors International, cutting an estimated $21.2M.
  • HM Payson & Co fully exited Vanguard Ultra-Short Bond ETF in Q1 2022, selling an estimated $3.01M.
  • HM Payson & Co's ten largest holdings make up 31% of its $4.39B portfolio in Q1 2022.
  • HM Payson & Co opened 99 new positions and closed 119 in Q1 2022.
  • HM Payson & Co's portfolio value fell 4.5% quarter-over-quarter to $4.39B.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.